Online citations, reference lists, and bibliographies.
← Back to Search

Oral Delivery Of Doxorubicin Using Novel Polyelectrolyte-stabilized Liposomes (layersomes).

S. Jain, Swapnil R. Patil, N. K. Swarnakar, A. Agrawal
Published 2012 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
The present study explores the potential of polyelectrolyte-coated liposomes for improving the oral deliverability of doxorubicin (Dox). As a part of formulation strategy, stearyl amine was selected as a formulation component to provide positive charge to liposomes, which were subsequently coated with anionic poly(acrylic acid) (PAA) followed by coating of cationic polyallyl amine hydrochloride (PAH) in a layer by layer manner and led to the formation of a robust structure "layersomes". Optimization of various process variables were carried out, and optimized formulation was found to have particle size of 520.4 ± 15.0 nm, PDI of 0.312 ± 0.062, ζ potential of +30.4 ± 5.32 mV, and encapsulation efficiency of 63.4 ± 4.26%. Layersomes were not only stable in simulated gastrointestinal fluids but also presented sustained drug release (∼35%) as compared to both Dox-liposomes and PAA-Dox-liposomes (∼67%), the release pattern being Higuchi kinetics. The in vivo pharmacokinetics studies revealed about 5.94-fold increase in oral bioavailability of Dox as compared to free drug. In vivo antitumor efficacy in a DMBA-induced breast tumor model further exhibited significant reduction in the tumor growth as compared to control and IV-Dox, while results were comparable to IV-LipoDox. Layersomes also exhibited a marked reduction in cardiotoxicity in comparison with IV-doxorubicin and IV-LipoDox (marketed formulation), as evidenced by the reduced levels of malondialdehyde (MDA), lactate dehydrogenase (LDH), and creatine phosphokinase (CK-MB) and increased levels of glutathione (GSH) and superoxide dismutase (SOD). The reduced cardiotoxicity of layersomes was further confirmed by comparative histopathological examination of heart tissue after treatment with various formulations. The positive results of the study strengthen our expectation that the developed formulation strategy can be fruitfully exploited to improve the oral deliverability of poorly bioavailable drugs and can open new vistas for oral chemotherapy.
This paper references
10.1016/j.biomaterials.2010.09.037
The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen.
A. Jain (2011)
10.1016/J.IJPHARM.2007.05.037
Layersome: development and optimization of stable liposomes as drug delivery system.
M. Ciobanu (2007)
10.1016/j.biomaterials.2009.12.043
The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
K. K. Upadhyay (2010)
10.1081/CNV-120014883
Pegylated Liposomal Doxorubicin (Doxil®) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience
A. Perez (2002)
10.1615/CRITREVTHERDRUGCARRIERSYST.V28.I1.10
Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics.
A. Jain (2011)
10.1080/10717540490280769
Stability of Liposomal Formulations in Physiological Conditions for Oral Drug Delivery
M. C. Taira (2004)
10.1046/j.1365-2141.2001.03171.x
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914)
P. Sonneveld (2001)
10.1146/ANNUREV.BB.09.060180.002343
Comparative properties and methods of preparation of lipid vesicles (liposomes).
F. Szoka (1980)
10.1124/pr.56.2.6
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
G. Minotti (2004)
Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
Z. Wu (2004)
Jr Second cancers following non - Hodgkin ’ s lymphoma
L. B. Travis (1991)
10.2147/IJN.S13031
Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats
A. Rudra (2010)
10.1007/s12272-011-0411-x
Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin
J. Choi (2011)
10.1023/A:1016030202104
Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Hongming Chen (2004)
10.1016/j.ijpharm.2011.11.035
Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
Derajram M Benival (2012)
10.1080/08982100500364131
The Effect of Cholesterol in the Liposome Bilayer on the Stabilization of Incorporated Retinol
S. Lee (2005)
10.1211/0022357022935
Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects
M. Vertzoni (2004)
10.1016/0378-5173(85)90217-0
Doxorubicin decomposition on storage: effect of pH, type of buffer and liposome encapsulation
M. Janssen (1985)
10.1016/0378-5173(86)90170-5
Aspects of the degradation kinetics of doxorubicin in aqueous solution
J. Beijnen (1986)
10.1007/s11095-008-9763-4
Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats
D. R. Kalaria (2008)
10.1093/ANNONC/MDH097
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.
M. O'Brien (2004)
10.1016/0005-2760(80)90131-9
The stability of liposomes in vitro to pH, bile salts and pancreatic lipase.
R. Rowland (1980)
10.1002/JPS.21155
Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system.
Weilun Ke (2008)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
10.1002/1097-0142(19910401)67:7<2002::AID-CNCR2820670729>3.0.CO;2-E
Second cancers following non‐Hodgkin's lymphoma
L. Travis (1991)
10.1021/mp8002539
Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection.
P. Jain (2009)
10.1021/mp200011f
Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
A. Jain (2011)



This paper is referenced by
10.2147/DDDT.S84046
Pirfenidone-loaded liposomes for lung targeting: preparation and in vitro/in vivo evaluation
H. Meng (2015)
10.1080/1061186X.2017.1298603
α-Tocopherol as functional excipient for resveratrol and coenzyme Q10-loaded SNEDDS for improved bioavailability and prophylaxis of breast cancer
S. Jain (2017)
10.1007/978-3-319-67720-0_10
Surface Modification of Radionanomedicine
Daiqin Chen (2018)
10.1016/j.colsurfb.2015.03.018
Improved stability and skin permeability of sodium hyaluronate-chitosan multilayered liposomes by Layer-by-Layer electrostatic deposition for quercetin delivery.
Soha Jeon (2015)
An Investigation into Formulation and Therapeutic Effectiveness of Nanoparticle Drug Delivery for Select Pharmaceutical Agents
D. L. Cooper (2016)
10.1016/j.xphs.2019.06.003
Nanostructured Lipid Carriers for oral bioavailability enhancement of Exemestane: Formulation design, in vitro, ex vivo and in vivo studies.
Archu Singh (2019)
IDENTIFYING DRUG-MICROBIOME INTERACTIONS: THE INACTIVATION OF DOXORUBICIN BY THE GUT BACTERIUM RAOULTELLA PLANTICOLA
Austin Yan (2015)
10.1039/C4TB00876F
Chitosan-coated nano-liposomes for the oral delivery of berberine hydrochloride.
T. X. Nguyen (2014)
10.1016/j.colsurfb.2014.02.028
Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof.
I. Levacheva (2014)
10.1039/C5RA14588K
Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studies
Guihua Fang (2015)
10.1016/j.apsb.2018.06.005
Adapting liposomes for oral drug delivery
Haisheng He (2019)
10.1021/acs.molpharmaceut.5b00281
Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles.
S. Jain (2015)
10.7314/APJCP.2014.15.19.8377
DOX-MTX-NPs augment p53 mRNA expression in OSCC model in rat: effects of IV and oral routes.
M. Abbasi (2014)
10.1039/C4TB00273C
Improving the oral delivery efficiency of anticancer drugs by chitosan coated polycaprolactone-grafted hyaluronic acid nanoparticles.
P. Huang (2014)
10.1007/s11095-013-1244-8
Bicontinuous Cubic Liquid Crystalline Nanoparticles for Oral Delivery of Doxorubicin: Implications on Bioavailability, Therapeutic Efficacy, and Cardiotoxicity
N. K. Swarnakar (2013)
10.1039/C8TB02756K
A hybrid 3D-printed aspirin-laden liposome composite scaffold for bone tissue engineering.
Y. Li (2019)
10.1016/j.ijpharm.2018.04.052
Redox‐responsive microbeads containing thiolated pectin‐doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study
Kamonrak Cheewatanakornkool (2018)
10.1021/acs.molpharmaceut.6b01099
"Liquid Crystalline Nanoparticles": Rationally Designed Vehicle To Improve Stability and Therapeutic Efficacy of Insulin Following Oral Administration.
A. Agrawal (2017)
10.1016/j.jconrel.2013.12.030
Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy.
C. Luo (2014)
10.2217/nnm.14.177
Development of dual toxoid-loaded layersomes for complete immunostimulatory response following peroral administration.
H. Harde (2015)
10.1016/j.ijpharm.2020.119682
Insight into the in vivo translocation of oral liposomes by fluorescence resonance energy transfer effect.
W. Liu (2020)
10.1039/C5RA12732G
Rationally developed core–shell polymeric-lipid hybrid nanoparticles as a delivery vehicle for cromolyn sodium: implications of lipid envelop on in vitro and in vivo behaviour of nanoparticles upon oral administration
Ravi R. Patel (2015)
10.1016/j.jconrel.2016.07.051
Role of nanoparticle size, shape and surface chemistry in oral drug delivery.
Amrita Banerjee (2016)
10.1007/978-3-319-11355-5_15
Multifunctional Polymeric Nano-Carriers in Targeted Drug Delivery
A. Agrawal (2015)
10.1039/C5RA03283K
Hyaluronic acid–PEI–cyclodextrin polyplexes: implications for in vitro and in vivo transfection efficiency and toxicity
S. Jain (2015)
10.1016/j.ejmech.2014.07.079
Synthesis and evaluation of the cytotoxic activity of 1,2-furanonaphthoquinones tethered to 1,2,3-1H-triazoles in myeloid and lymphoid leukemia cell lines.
M. Cardoso (2014)
10.1016/j.nano.2014.03.003
Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using Doxorubicin- and Coenzyme Q10-liquid crystalline nanoparticles in comparison with intravenous Adriamycin.
N. K. Swarnakar (2014)
10.4103/2277-9175.178781
Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes
Somayeh Taymouri (2016)
10.2217/nnm-2017-0007
Doxorubicin-loaded liposomes: enhancing the oral bioavailability by modulation of physicochemical characteristics.
Marjan Daeihamed (2017)
10.1021/mp500833m
Improved oral absorption of doxorubicin by amphiphilic copolymer of lysine-linked ditocopherol polyethylene glycol 2000 succinate: in vitro characterization and in vivo evaluation.
J. Wang (2015)
10.2217/nnm.16.36
Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus.
Nirmal Marasini (2016)
Nanotechnology in Drug Delivery 52 3 Nanotechnology systems for oral drug delivery : challenges and opportunities
Alberto Berardi (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar